SciVision Biotech Inc (1786) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.007x

Based on the latest financial reports, SciVision Biotech Inc (1786) has a cash flow conversion efficiency ratio of -0.007x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-13.02 Million ≈ $-410.33K USD) by net assets (NT$1.98 Billion ≈ $62.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of SciVision Biotech Inc to measure how much of total assets are equity-financed.

SciVision Biotech Inc - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how SciVision Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SciVision Biotech Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

SciVision Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SciVision Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
EcoSynthetix Inc TO:ECO	0.014x
Power Root Bhd KLSE:7237	0.081x
Hitejinro Holdings KO:000140	-0.020x
Creative Newtech Limited NSE:CREATIVE	-0.268x
The Hi-Tech Gears Limited NSE:HITECHGEAR	0.043x
Apiam Animal Health Ltd AU:AHX	0.076x
Kalray SA PA:ALKAL	0.230x
Ryder Capital Ltd AU:RYD	-0.005x

Annual Cash Flow Conversion Efficiency for SciVision Biotech Inc (2009–2025)

The table below shows the annual cash flow conversion efficiency of SciVision Biotech Inc from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see how much is SciVision Biotech Inc worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$1.98 Billion ≈ $62.39 Million	NT$123.99 Million ≈ $3.91 Million	0.063x	-55.99%
2024-12-31	NT$1.90 Billion ≈ $59.77 Million	NT$269.87 Million ≈ $8.50 Million	0.142x	-14.94%
2023-12-31	NT$1.63 Billion ≈ $51.24 Million	NT$272.01 Million ≈ $8.57 Million	0.167x	+41.79%
2022-12-31	NT$1.51 Billion ≈ $47.60 Million	NT$178.21 Million ≈ $5.61 Million	0.118x	+73.60%
2021-12-31	NT$1.45 Billion ≈ $45.68 Million	NT$98.51 Million ≈ $3.10 Million	0.068x	-24.57%
2020-12-31	NT$1.40 Billion ≈ $44.24 Million	NT$126.47 Million ≈ $3.98 Million	0.090x	-40.04%
2019-12-31	NT$1.36 Billion ≈ $42.87 Million	NT$204.40 Million ≈ $6.44 Million	0.150x	+44.98%
2018-12-31	NT$1.08 Billion ≈ $33.97 Million	NT$111.70 Million ≈ $3.52 Million	0.104x	+492.97%
2017-12-31	NT$914.45 Million ≈ $28.81 Million	NT$15.98 Million ≈ $503.39K	0.017x	-59.19%
2016-12-31	NT$894.21 Million ≈ $28.17 Million	NT$38.29 Million ≈ $1.21 Million	0.043x	-18.46%
2015-12-31	NT$948.60 Million ≈ $29.89 Million	NT$49.81 Million ≈ $1.57 Million	0.053x	+2800.57%
2014-12-31	NT$1.02 Billion ≈ $32.23 Million	NT$1.85 Million ≈ $58.35K	0.002x	-94.74%
2013-12-31	NT$1.08 Billion ≈ $34.15 Million	NT$37.27 Million ≈ $1.17 Million	0.034x	-71.56%
2012-12-31	NT$425.98 Million ≈ $13.42 Million	NT$51.52 Million ≈ $1.62 Million	0.121x	+18.47%
2011-12-31	NT$363.70 Million ≈ $11.46 Million	NT$37.13 Million ≈ $1.17 Million	0.102x	+66.58%
2010-12-31	NT$111.73 Million ≈ $3.52 Million	NT$6.85 Million ≈ $215.72K	0.061x	+114.28%
2009-12-31	NT$84.09 Million ≈ $2.65 Million	NT$-36.09 Million ≈ $-1.14 Million	-0.429x	--

About SciVision Biotech Inc

TW:1786 Taiwan Medical Instruments & Supplies

Market Cap

$116.46 Million

NT$3.70 Billion TWD

Market Cap Rank

#18538 Global

#990 in Taiwan

Share Price

NT$49.40

Change (1 day)

+1.86%

52-Week Range

NT$48.50 - NT$114.50

All Time High

NT$136.50